相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Prognostic Value of Serum AFP, AFP-L3, and GP73 in Monitoring Short-term Treatment Response and Recurrence of Hepatocellular Carcinoma after Radiofrequency Ablation
Nan-Ya Wang et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2014)
Epigenetic Mechanism Involved in the HBV/HCV-Related Hepatocellular Carcinoma Tumorigenesis
Liang Rongrui et al.
CURRENT PHARMACEUTICAL DESIGN (2014)
Mediterranean diet and hepatocellular carcinoma
Federica Turati et al.
JOURNAL OF HEPATOLOGY (2014)
Diagnostic value of alpha fucosidase for hepatocellular carcinoma: a meta-analysis
Yuling Gan et al.
TUMOR BIOLOGY (2014)
Comparing Prothrombin induced by vitamin K absence-II (PIVKA-II) with the oncofetal proteins Glypican-3, Alpha feto protein and Carcinoembryonic antigen in diagnosing hepatocellular carcinoma among Egyptian patients
Iman A. Abd El Gawad et al.
JOURNAL OF THE EGYPTIAN NATIONAL CANCER INSTITUTE (2014)
Combined use of AFP, CEA, CA125 and CA19-9 improves the sensitivity for the diagnosis of gastric cancer
Chao-Zhu He et al.
BMC GASTROENTEROLOGY (2013)
Evaluation of Individual and Combined Applications of Serum Biomarkers for Diagnosis of Hepatocellular Carcinoma: A Meta-Analysis
Bin Hu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
Diagnostic value of AFP-L3 and PIVKA-II in hepatocellular carcinoma according to total-AFP
Jong Young Choi et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
Correlation analysis of preoperative serum alpha-fetoprotein (AFP) level and prognosis of hepatocellular carcinoma (HCC) after hepatectomy
Wen-jun Ma et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2013)
Golgi protein 73 versus alpha-fetoprotein as a biomarker for hepatocellular carcinoma: a diagnostic meta-analysis
Ying Zhou et al.
BMC CANCER (2012)
Simultaneous electrochemical immunoassay of three liver cancer biomarkers using distinguishable redox probes as signal tags and gold nanoparticles coated carbon nanotubes as signal enhancers
Ya Li et al.
CHEMICAL COMMUNICATIONS (2012)
Diagnostic and Prognostic Validity of Golgi Protein 73 in Hepatocellular Carcinoma (Retraction of vol 83, pg 83, 2011)
Hasan Oezkan et al.
DIGESTION (2012)
Hepatocellualar Carcinoma Serum Markers
Gaetano Bertino et al.
SEMINARS IN ONCOLOGY (2012)
α-Fetoprotein
M. J. Murray et al.
ARCHIVES OF DISEASE IN CHILDHOOD-EDUCATION AND PRACTICE EDITION (2011)
Clinical utility of highly sensitive Lens culinaris agglutinin-reactive alpha-fetoprotein in hepatocellular carcinoma patients with alpha-fetoprotein <20 ng/mL
Hidenori Toyoda et al.
CANCER SCIENCE (2011)
A comparative evaluation of Golgi protein-73, fucosylated hemopexin, α-fetoprotein, and PIVKA-II in the serum of patients with chronic hepatitis, cirrhosis, and hepatocellular carcinoma
Kaori Morota et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2011)
Diagnostic and Prognostic Validity of Golgi Protein 73 in Hepatocellular Carcinoma
Hasan Ozkan et al.
DIGESTION (2011)
Alpha-fetoprotein above normal levels as a risk factor for the development of hepatocellular carcinoma in patients infected with hepatitis C virus
Masakuni Tateyama et al.
JOURNAL OF GASTROENTEROLOGY (2011)
Serum Markers of Hepatocellular Carcinoma
Giulia Malaguarnera et al.
DIGESTIVE DISEASES AND SCIENCES (2010)
Golgi protein 73 (GOLPH2) is a valuable serum marker for hepatocellular carcinoma
Yilei Mao et al.
GUT (2010)
AFP, AFP-L3, DCP, and GP73 as markers for monitoring treatment response and recurrence and as surrogate markers of clinicopathological variables of HCC
Kentaroh Yamamoto et al.
JOURNAL OF GASTROENTEROLOGY (2010)
Automated immunoassay system for AFP-L3% using on-chip electrokinetic reaction and separation by affinity electrophoresis
Chiaki Kagebayashi et al.
ANALYTICAL BIOCHEMISTRY (2009)
Novel Fucosylated Biomarkers for the Early Detection of Hepatocellular Carcinoma
Mengjun Wang et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2009)
α-Fetoprotein, Des-γ Carboxyprothrombin, and Lectin-Bound α-Fetoprotein in Early Hepatocellular Carcinoma
Jorge A. Marrero et al.
GASTROENTEROLOGY (2009)
Serum Golgi Phosphoprotein 2 Level: A Better Marker Than Alpha-Fetoprotein for Diagnosing Early Hepatocellular Carcinoma
Xiaohua Li et al.
HEPATOLOGY (2009)
Liver fibrosis: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL)
Gamal Shiha et al.
HEPATOLOGY INTERNATIONAL (2009)
Diagnosis and Treatment of Intracranial Immature Teratoma
Xiang Huang et al.
PEDIATRIC NEUROSURGERY (2009)
Towards an integrated proteomic and glycomic approach to finding cancer biomarkers
Allen D. Taylor et al.
GENOME MEDICINE (2009)
Quantitative analysis of elevated serum Golgi protein-73 expression in patients with liver diseases
Yanli Gu et al.
ANNALS OF CLINICAL BIOCHEMISTRY (2009)
Diagnosing and monitoring hepatocellular carcinoma with alpha-fetoprotein: New aspects and applications
Evi N. Debruyne et al.
CLINICA CHIMICA ACTA (2008)
Hepatoblastoma with a low serum alpha-fetoprotein level at diagnosis: The SIOPEL group experience
Maretta De Ioris et al.
EUROPEAN JOURNAL OF CANCER (2008)
N-Linked Glycosylation of the Liver Cancer Biomarker GP73
Pamela A. Norton et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2008)
Glycomic analysis of alpha-fetoprotein L3 in hepatoma cell lines and hepatocellular carcinoma patients
Takatoshi Nakagawa et al.
JOURNAL OF PROTEOME RESEARCH (2008)
AFP-L3: a new generation of tumor marker for hepatocellular carcinoma
D Li et al.
CLINICA CHIMICA ACTA (2001)
GP73, a novel Golgi-localized protein upregulated by viral infection
RD Kladney et al.
GENE (2000)
分享论文
